发明名称 PHENYLIMIDAZOLIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITION BASED THEREON
摘要 FIELD: pharmaceutical industry. SUBSTANCE: present invention describes novel phenylimidazolidinone derivatives of general formula 1: <EMI ID=0.412 HE=21 WI=57 TI=CHI> wherein n is 1, R<SB>1</SB> and R<SB>2</SB> are hydrogen, halogen, CN, C<SB>1</SB>-C<SB>6</SB> alkyl, C<SB>1</SB>-C<SB>6</SB> alkoxy, C<SB>1</SB>-C<SB>6</SB> alkylthio, CF<SB>3</SB>, NO<SB>2</SB>,; R<SB>3</SB> is group II <EMI ID=0.413 HE=18 WI=27 TI=CHI> or group III <EMI ID=0.414 HE=21 WI=15 TI=CHI>; R<SB>4</SB> is H or C<SB>1</SB>-C<SB>6</SB> alkyl; R<SB>5</SB> is H, C<SB>1</SB>-C<SB>6</SB> alkyl or nitrogen protecting group, or pharmaceutically acceptable salt thereof. Said compounds are useful as active ingredient in pharmaceutical composition having 5HT<SB>3</SB> antagonistic activity. EFFECT: improved properties of the pharmaceutical composition. 6 cl, 7 ex, 2 tbl
申请公布号 RU2126403(C1) 申请公布日期 1999.02.20
申请号 RU19940036775 申请日期 1993.10.22
申请人 FARMATSIJA EHND APDZHON C.P.A. 发明人 MARIO VARAZI;FRANKO EHJDEMPERGER;KARLA KACHCHIJA;KLAUDIO ARRIGONI
分类号 C07D403/06;A61K31/415;A61K31/4178;A61P1/00;A61P1/08;A61P25/00;A61P25/04;A61P25/06;A61P25/20;A61P25/26;C07D233/32;C07D233/54;C07D233/56;C07D233/61;(IPC1-7):C07D403/06 主分类号 C07D403/06
代理机构 代理人
主权项
地址